Delivery Order SPE2DB20D2104-SPE2DB25FMSFB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,109.14 to AmerisourceBergen Drug Corp for the supply of Timolol 0.25% Gel-Solution 5ML, an ophthalmic medication used to treat glaucoma and ocular hypertension. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 13, 2025. The contract was fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,633.77 to AmerisourceBergen Drug Corp for the supply of Timolol 0.25% Gel-Solution 5ML, an ophthalmic medication used to treat glaucoma and ocular hypertension. The contract, awarded on July 11, 2025, with an ultimate completion date of July 14, 2025, was competitively awarded without set-aside designation under firm fixed-price terms. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,818.40 to AmerisourceBergen Drug Corp for the supply of Timolol 0.5% Gel-Solution 5mL, a topical ophthalmic medication commonly used to treat glaucoma and ocular hypertension. This firm fixed-price delivery order, issued on August 8, 2025, was competitively awarded with no set-aside designation and carries an ultimate completion date of August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order contract valued at $31,449.71 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML, a topical ophthalmic medication used in treating glaucoma and ocular hypertension. This firm fixed price delivery order was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order valued at $7,185.79 to AmerisourceBergen Drug Corp for the supply of Timolol 0.5% Gel-Solution 5ML, an ophthalmic medication used to treat glaucoma and ocular hypertension. The contract is a firm fixed price delivery order with an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was...
- The Defense Logistics Agency awarded a delivery order valued at $10,886.71 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Timolol is a beta-blocker medication commonly used to treat glaucoma and ocular...
- The Defense Logistics Agency awarded a delivery order valued at $4,540.02 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor...
- The Defense Logistics Agency awarded a delivery order valued at $11,953.10 to AmerisourceBergen Drug Corp for Timolol 0.5% gel-solution in 5ml units. This non-competitive, firm fixed-price delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Timolol is a beta-blocker medication primarily used for glaucoma treatment and post-operative eye care,...
- The Defense Logistics Agency awarded a delivery order valued at $1,202.08 to AmerisourceBergen Drug Corp for Timolol 0.25% gel-solution in 5ml quantities. This competitively awarded, non-set-aside contract was executed on September 22, 2025, with an ultimate completion date of September 23, 2025, and utilizes firm fixed price terms. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Timolol 0.5% gel-solution in 5ml units, with a ceiling value of $2,263.62 and a firm fixed price structure. This delivery order, which is not set-aside and represents a competitively awarded contract, will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 23, 2025. The contract is a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMSFBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,963.88 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML, an ophthalmic medication commonly used to treat glaucoma and ocular hypertension. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a broader Indefinite Delivery Contract vehicle with the Defense Logistics Agency. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company holds a significant IDC with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which enables comprehensive global pharmaceutical support for military healthcare programs. Through this contract vehicle and associated delivery orders, AmerisourceBergen supplies an extensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 6/2/25 |